PDE5a inhibitors like sildenafil reduce cancer metastasis by disrupting NPC1-mediated cholesterol trafficking, causing lysosomal cholesterol accumulation and impairing cell migration.
- Open access
Moving in bioRxiv, BMJ, Cancer Research, Cell Reports, eLife, Frontiers in Genetics, Neuron.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
PDE5a inhibitors like sildenafil reduce cancer metastasis by disrupting NPC1-mediated cholesterol trafficking, causing lysosomal cholesterol accumulation and impairing cell migration.
Using CD115 instead of CLEC12A improves the precision of defining human common monocyte progenitors, revealing their molecular complexity.
Integrating targeted genetic approaches with genome-wide evidence enhances clinical pharmacogenetics in psychiatry, especially for pharmacokinetic and pharmacodynamic traits.
Dendritic spine nanostructure analysis reveals that increased Ecrg4 expression links to schizophrenia-related spine abnormalities in mouse models.
Azithromycin reduces the risk of moderate or severe COPD exacerbations by 17% compared to roflumilast in routine clinical practice among patients over 40.
Journals this month
Moving areas, week to 3 Oct 2026